How Many Doses Are in a Mounjaro Pen? Single-Use Capacity Explained

Trust signals

> Reviewed by FormBlends Medical Team · Last updated May 2026 · 11 sources cited · Author: FormBlends Editorial

Key Takeaways

• Each Mounjaro pen is a single-use auto-injector containing exactly one weekly dose of tirzepatide.
• A four-week supply is four pens, each used once and discarded.
• Mounjaro comes in six dose strengths (2.5, 5, 7.5, 10, 12.5, 15 mg); each strength is a separate pen format.
• The single-use design eliminates dose-dialing errors but increases packaging volume and per-dose plastic waste.
• Mounjaro is FDA-approved for type 2 diabetes; the same molecule and pen format are sold as Zepbound for chronic weight management.

Direct answer

A Mounjaro pen contains one dose. The pen is a single-use auto-injector pre-loaded with a fixed amount of tirzepatide at the strength printed on the label. After activation, the pen is empty (apart from residual volume) and is discarded. A standard one-month Mounjaro supply consists of four separate pens, one for each weekly injection.

Table of contents

1. One pen, one dose: the Mounjaro format
2. How a four-week supply is packaged
3. The six dose strengths of Mounjaro
4. How single-use auto-injectors work mechanically
5. Why Eli Lilly chose this format
6. Storage and the 21-day room-temperature window
7. Mounjaro vs Zepbound: same drug, different label
8. Comparison to multi-dose Ozempic pens
9. The contrary view on single-use packaging
10. Decision framework
11. FAQ
12. Sources

One pen, one dose: the Mounjaro format

Mounjaro is sold as a single-use auto-injector pen pre-filled by Eli Lilly with a fixed dose of tirzepatide. The patient holds the pen against the skin, presses the activation button, and the pen delivers the dose in a few seconds. The auto-injector mechanism fires once, then the pen is spent.

There is no dose dial. There is no dose-counter window. There is no priming step. The patient does not measure, count, or adjust. The pen is engineered to deliver exactly what is printed on its label.

How a four-week supply is packaged

A standard Mounjaro fill from a U.S. pharmacy includes four pens of the same dose strength. The package is a cardboard carton containing four blister-sealed pens, each with its own instructions for use insert. The pens are refrigerated until use.

Element	Per pen	Per four-week supply
Doses	1	4
Tirzepatide content	Strength on label (2.5, 5, 7.5, 10, 12.5, or 15 mg)	4 x strength
Pen plastic	Single auto-injector body	4 separate pens
Refrigeration required	Until use	Throughout storage

The six dose strengths of Mounjaro

Mounjaro is available in six dose strengths. Each strength is a different pen with the dose pre-loaded:

• 2.5 mg (starting dose, weeks 1-4)
• 5 mg
• 7.5 mg
• 10 mg
• 12.5 mg
• 15 mg (maximum)

The labeled titration schedule from Eli Lilly: 2.5 mg weekly for 4 weeks, then 5 mg weekly for at least 4 weeks. Further increases are made in 2.5 mg increments at intervals of at least 4 weeks, based on tolerance and clinical response. The maximum recommended dose is 15 mg weekly.

A patient escalating from 2.5 mg to 15 mg over the standard schedule receives six different pen strengths over a minimum of 20 weeks of titration. Each strength is a separate fill from the pharmacy.

How single-use auto-injectors work mechanically

The Mounjaro pen is a spring-loaded auto-injector. The mechanism has three states: armed (out of the carton, ready to use), fired (button pressed, needle deployed, drug delivered), and spent (cannot be reset).

Operating the pen per Eli Lilly's instructions for use:

1. Remove the pen from refrigeration and the carton.
2. Inspect the medication through the viewing window (should be clear and colorless).
3. Pull off the base cap to expose the needle area (the needle is internal and not visible).
4. Press the pen firmly against the injection site (abdomen, thigh, or upper arm).
5. Press the button. Hold for approximately 10 seconds while the pen delivers the dose.
6. Lift the pen and dispose of it in a sharps container.

The pen will not fire unless it is pressed firmly against the skin. The mechanism includes a safety lockout that prevents accidental activation in the air.

Why Eli Lilly chose this format

Single-use auto-injectors trade convenience features for error reduction. The design rationale has several pieces.

First, dose precision. A pre-loaded dose cannot be miscounted, mis-dialed, or accidentally over- or under-delivered by the patient. Whatever is in the pen is what is delivered, full stop.

Second, stability. Single-use pens are sealed at manufacturing and stay sealed until use. The cartridge does not face air exposure, partial use, or storage cycles between doses. This simplifies the stability data Eli Lilly had to submit for FDA approval.

Third, user error reduction. The auto-injector mechanism eliminates the priming step, the dose-dial step, and the audible click confirmation that multi-dose pens require. For first-time users, the format is more forgiving.

Fourth, training simplicity. Pharmacists and prescribers can train a patient on Mounjaro in less time than on a multi-dose dial-based device.

Storage and the 21-day room-temperature window

Mounjaro pens require refrigeration until use, per Eli Lilly's storage instructions. The pens can be kept at room temperature (up to 86 F / 30 C) for up to 21 days, after which any unused pen should be discarded.

The 21-day room-temperature window is shorter than Ozempic's 56-day window. This matters for patients who travel or who cannot reliably refrigerate their pens. A four-week supply of Mounjaro left at room temperature for the full month would exceed the labeled limit on the fourth pen.

Storage condition	Mounjaro pen	Ozempic pen (for comparison)
Refrigerated, unopened	Until expiration	Until expiration
Room temperature window	21 days	56 days
Maximum room temperature	86 F / 30 C	86 F / 30 C
Light exposure	Keep in original carton	Keep in original carton

Mounjaro vs Zepbound: same drug, different label

Mounjaro and Zepbound are the same molecule (tirzepatide) in the same pen format. The difference is the FDA-approved indication:

• Mounjaro: type 2 diabetes (approved May 2022).
• Zepbound: chronic weight management in obesity or overweight with comorbidities (approved November 2023).

The pens are identical in mechanism. The packaging and labeling differ. Insurance coverage may differ substantially: a payer that covers Mounjaro for diabetes may not cover Zepbound for obesity, and vice versa. Patients should not assume their plan treats them as interchangeable.

Comparison to multi-dose Ozempic pens

Mounjaro and Ozempic are both GLP-1-class injectables, but the pen designs are fundamentally different. Ozempic is semaglutide in a multi-dose pen; Mounjaro is tirzepatide in a single-use pen.

Feature	Mounjaro	Ozempic
Molecule	Tirzepatide (GIP/GLP-1 dual agonist)	Semaglutide (GLP-1)
Pen format	Single-use auto-injector	Multi-dose dial pen
Doses per pen	1	4 (or 8 on starter pen)
Doses per four-week supply	4 separate pens	1 pen
Dose strengths available	2.5, 5, 7.5, 10, 12.5, 15 mg	0.25, 0.5, 1, 2 mg (4 pen formats)
Room-temp window	21 days	56 days
Dial / count clicks	No	Yes

The contrary view on single-use packaging

The single-use auto-injector format has critics.

Argument 1: plastic waste. Four pens per month per patient generates more plastic and packaging than a single multi-dose pen. Across millions of users, the environmental footprint is meaningfully larger.

Argument 2: refrigerator space. Four separate boxes per month take more space than one Ozempic pen.

Argument 3: per-dose cost. Single-use packaging is more expensive to manufacture and ship than multi-dose cartridges. List prices for Mounjaro and Zepbound are roughly equivalent to Ozempic and Wegovy at comparable doses, but the cost structure differs.

Argument 4: titration friction. Each new dose strength requires a new pharmacy fill. A patient escalating across all six strengths over 20-24 weeks faces more refill events than an Ozempic patient using two or three pen formats over the same period.

Counter-arguments: dose errors are rare with auto-injectors, training is simpler, stability concerns are reduced, and the format works for patients who would struggle with dialing. The trade-off is real, but Eli Lilly's bet has been validated in regulatory and market terms.

Decision framework

If you are starting Mounjaro:

• You will receive a fill of four 2.5 mg pens for the first month.
• One pen per week, refrigerated until use, injected once and discarded.

If you are titrating to a higher dose:

• Your prescriber will write for the new strength. The pharmacy fills four pens at the new dose.
• Do not use leftover pens from the previous strength; the dose printed on the label is the dose delivered.

If you are choosing between Mounjaro and Ozempic for diabetes:

• Mounjaro's auto-injector format is easier for new injectors; Ozempic's multi-dose format is easier for travel and refill cadence.
• Discuss with your prescriber. The choice often comes down to insurance coverage and personal preference.

What this means for your dose schedule

Follow your prescriber's instructions, and do not adjust dose without their approval.

Compounded medication note for this topic

For How Many Doses Are in a Mounjaro Pen? Single-Use Capacity Explained, keep the pharmacy distinction clear: when compounded semaglutide or tirzepatide is prescribed, it is prepared for an individual patient by a licensed 503A compounding pharmacy. Compounded preparations are not FDA-approved drug products and are not interchangeable with Ozempic, Wegovy, Mounjaro, or Zepbound.

The practical question is not whether a compounded medication is a brand substitute. It is whether the prescription, pharmacy label, concentration, follow-up plan, and adverse-event support are clear enough for your specific medical history.

FAQ

How many doses are in a Mounjaro pen? One. The pen is a single-use auto-injector with a fixed dose.

Why is the Mounjaro pen single-use? The design eliminates dose-dialing errors and simplifies stability and storage requirements.

How does a four-week Mounjaro supply work? Four pens of the same dose strength, one per week.

Can a Mounjaro pen be re-used if it has medication left? No. The auto-injector mechanism fires once and cannot be reset.

What are the Mounjaro dose strengths? 2.5, 5, 7.5, 10, 12.5, and 15 mg.

How does this compare to Ozempic? Ozempic is a multi-dose dial pen (4 to 8 doses per pen). Mounjaro is single-use (1 dose per pen).

Is Zepbound also single-use? Yes. Same molecule, same pen format, different FDA-approved indication.

Does the Mounjaro pen need to be refrigerated until use? Yes. Refrigerated until use, room-temperature window of 21 days, max 86 F / 30 C.

What if I drop a Mounjaro pen? Inspect for cracks or damage. If anything looks compromised, do not use it. Contact your pharmacist for guidance.

How long does the injection take? Per Eli Lilly's instructions, hold the pen against the skin for approximately 10 seconds while the dose delivers.

Can I switch from Mounjaro to Ozempic if I prefer the multi-dose format? Talk to your prescriber. The medications are different molecules with different titration schedules, so a switch is not just a format change.

Sources

1. Eli Lilly. Mounjaro (tirzepatide) injection prescribing information. Revised 2024.
2. Eli Lilly. Mounjaro Instructions for Use. 2023.
3. Eli Lilly. Zepbound (tirzepatide) injection prescribing information. Revised 2024.
4. FDA. Mounjaro approval letter. May 2022.
5. FDA. Zepbound approval letter. November 2023.
6. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
7. Aronne LJ et al. SURMOUNT-4: Continued tirzepatide treatment for weight maintenance. JAMA. 2024.
8. Frias JP et al. SURPASS-2: Tirzepatide vs semaglutide. New England Journal of Medicine. 2021.
9. ADA. Standards of Care in Diabetes 2026.
10. Endocrine Society. Clinical Practice Guideline on Pharmacologic Management of Obesity. 2015 (updated 2024).
11. ISMP. Auto-Injector Safety Best Practices. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends connects patients with independently licensed clinicians and U.S. pharmacies. Mounjaro is dispensed only by licensed pharmacies and is not handled directly by FormBlends.

Compounded Medication Notice. Compounded tirzepatide is not FDA-approved and does not use the Eli Lilly auto-injector pen. Compounded preparations ship as vials and require patient-administered syringe drawing.

Results Disclaimer. Tirzepatide outcomes vary. SURMOUNT and SURPASS trial data reference mean values across study populations; individual results may differ.

Trademark Notice. Mounjaro, Zepbound, and Trulicity are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with Eli Lilly or Novo Nordisk.